You're correct about this one, Island. I can't see any sense in issuing X number of shares for this deal and then reverse splitting them. That would only make it more difficult for the Medite principals to rapidly increase the value of their holding.
As discussed earlier, the Cytocore reverse split was (possibly) a tactic to actually devalue the stock so that the insiders could scoop it up for less outlay. No such motive exists after this deal. With 80% of the outstanding shares, the Medite couple would lose more by trying to cheapen the other 20% than by just growing the value of the market cap as rapidly as they can.
The number of shares will have little to no effect on the price of the stock unless the Medite principals were to dump their 80%. They have literally no reason to try to dump their 80%. They have real products, real customers, and real business relationships throughout this line of business. That isn't a pump and dump scenario. That's a "Let's get filthy rich" scenario, if they can pull it off.
News 
Market Data 
Discover 
